{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T15:44:19Z","timestamp":1769183059409,"version":"3.49.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"24","funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-142221"],"award-info":[{"award-number":["MOP-142221"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes & Digestive & Kidney Diseases","doi-asserted-by":"publisher","award":["5R01DK075302"],"award-info":[{"award-number":["5R01DK075302"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000082","name":"Cystic Fibrosis Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,15]]},"DOI":"10.1093\/hmg\/ddx367","type":"journal-article","created":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T23:06:35Z","timestamp":1506899195000},"page":"4873-4885","source":"Crossref","is-referenced-by-count":43,"title":["Mutation-specific downregulation of CFTR2 variants by gating potentiators"],"prefix":"10.1093","volume":"26","author":[{"given":"Radu G","family":"Avramescu","sequence":"first","affiliation":[{"name":"Department of Physiology, McGill University, Montr\u00e9al, QC H3G 1Y6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Kai","sequence":"additional","affiliation":[{"name":"Department of Physiology, McGill University, Montr\u00e9al, QC H3G 1Y6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Physiology, McGill University, Montr\u00e9al, QC H3G 1Y6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lien","family":"Bidaud-Meynard","sequence":"additional","affiliation":[{"name":"Department of Physiology, McGill University, Montr\u00e9al, QC H3G 1Y6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Schn\u00far","sequence":"additional","affiliation":[{"name":"Department of Physiology, McGill University, Montr\u00e9al, QC H3G 1Y6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saul","family":"Frenkiel","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, Jewish General Hospital, Montr\u00e9al, QC H2T 1E2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Matouk","sequence":"additional","affiliation":[{"name":"Adult Cystic Fibrosis Clinic, Montreal Chest Institute, Respiratory Division, McGill University, Montr\u00e9al, QC H4A 3J1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Veit","sequence":"additional","affiliation":[{"name":"Department of Physiology, McGill University, Montr\u00e9al, QC H3G 1Y6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gergely L","family":"Lukacs","sequence":"additional","affiliation":[{"name":"Department of Physiology, McGill University, Montr\u00e9al, QC H3G 1Y6, Canada"},{"name":"Department of Biochemistry, McGill University, Montr\u00e9al, QC H3G 1Y6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,10,4]]},"reference":[{"key":"key\n\t\t\t\t20180314012236_ddx367-B1","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"N. Engl. J. Med"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: from molecular understanding to clinical application","volume":"16","author":"Cutting","year":"2015","journal-title":"Nat. Rev. Genet"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1146\/annurev.biochem.75.103004.142532","article-title":"CFTR function and prospects for therapy","volume":"77","author":"Riordan","year":"2008","journal-title":"Annu. Rev. Biochem"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B4","author":"CFTR2 Database"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B5","author":"Cystic Fibrosis Mutation Database"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1172\/JCI115582","article-title":"Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia","volume":"89","author":"Denning","year":"1992","journal-title":"J. Clin. Invest"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B7","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1073\/pnas.88.20.9262","article-title":"Immunocytochemical localization of the cystic fibrosis gene product CFTR","volume":"88","author":"Crawford","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B8","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ng.2745","article-title":"Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene","volume":"45","author":"Sosnay","year":"2013","journal-title":"Nat. Genet"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molmed.2011.10.003","article-title":"CFTR: folding, misfolding and correcting the DeltaF508 conformational defect","volume":"18","author":"Lukacs","year":"2012","journal-title":"Trends Mol. Med"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1091\/mbc.E14-04-0935","article-title":"From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations","volume":"27","author":"Veit","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B11","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0092-8674(93)90353-R","article-title":"Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis","volume":"73","author":"Welsh","year":"1993","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B12","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1056\/NEJMc1213681","article-title":"Ivacaftor in a G551D Homozygote with Cystic Fibrosis","volume":"369","author":"Harrison","year":"2013","journal-title":"N. Eng. J. Med"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/humu.10041","article-title":"Cystic fibrosis: a worldwide analysis of CFTR mutations\u2013correlation with incidence data and application to screening","volume":"19","author":"Bobadilla","year":"2002","journal-title":"Hum. Mut"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B14","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1113\/jphysiol.2014.271817","article-title":"Revertant mutants modify, but do not rescue, the gating defect of the cystic fibrosis mutant G551D-CFTR","volume":"592","author":"Xu","year":"2014","journal-title":"J. Physiol"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B15","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N. Engl. J. Med"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B16","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1164\/rccm.201609-1954OC","article-title":"Restoring cystic fibrosis transmembrane conductance regulator function reduces airway bacteria and inflammation in people with cystic fibrosis and chronic lung infections","volume":"195","author":"Hisert","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B17","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0909825","article-title":"Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation","volume":"363","author":"Accurso","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B18","doi-asserted-by":"crossref","first-page":"e88564.","DOI":"10.1371\/journal.pone.0088564","article-title":"A little CFTR goes a long way: CFTR-dependent sweat secretion from G551D and R117H-5T cystic fibrosis subjects taking ivacaftor","volume":"9","author":"Char","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jcf.2011.12.005","article-title":"Ivacaftor potentiation of multiple CFTR channels with gating mutations","volume":"11","author":"Yu","year":"2012","journal-title":"J. Cyst. Fibros"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B20"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nchembio.1253","article-title":"Mechanism-based corrector combination restores \u0394F508-CFTR folding and function","volume":"9","author":"Okiyoneda","year":"2013","journal-title":"Nat. Chem. Biol"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B22","doi-asserted-by":"crossref","first-page":"246ra297.","DOI":"10.1126\/scitranslmed.3008889","article-title":"Some gating potentiators, including VX-770, diminish \u0394F508-CFTR functional expression","volume":"6","author":"Veit","year":"2014","journal-title":"Sci. Transl. Med"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B23","doi-asserted-by":"crossref","first-page":"246ra296.","DOI":"10.1126\/scitranslmed.3008680","article-title":"Potentiator ivacaftor abrogates pharmacological correction of \u0394F508 CFTR in cystic fibrosis","volume":"6","author":"Cholon","year":"2014","journal-title":"Sci. Transl. Med"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B24","doi-asserted-by":"crossref","first-page":"7375.","DOI":"10.1038\/s41598-017-07504-1","article-title":"Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators","volume":"7","author":"Pranke","year":"2017","journal-title":"Sci. Rep"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcf.2013.06.008","article-title":"Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function","volume":"13","author":"Van Goor","year":"2014","journal-title":"J. Cyst. Fibros"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nprot.2016.174","article-title":"Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens","volume":"12","author":"Liu","year":"2017","journal-title":"Nat. Protoc"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ajpath.2011.10.036","article-title":"ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells","volume":"180","author":"Liu","year":"2012","journal-title":"Am. J. Pathol"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1165\/rcmb.2016-0276MA","article-title":"Pharmacological rescue of conditionally reprogrammed cystic fibrosis bronchial epithelial cells","volume":"56","author":"Gentzsch","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1165\/rcmb.2013-0071OC","article-title":"Breaking the in vitro alveolar type II cell proliferation barrier while retaining ion transport properties","volume":"50","author":"Bove","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B30","first-page":"e50646","article-title":"Culturing of human nasal epithelial cells at the air liquid interface","volume":"80","author":"Muller","year":"2013","journal-title":"J. Vis. Exp"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B31","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B32"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B33","author":"European Medicines Agency"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/bph.13365","article-title":"Low free drug concentration prevents inhibition of F508del CFTR functional expression by the potentiator VX-770 (ivacaftor)","volume":"173","author":"Matthes","year":"2016","journal-title":"Br. J. Pharmacol"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00441-005-0062-7","article-title":"Towards an in vitro model of cystic fibrosis small airway epithelium: characterisation of the human bronchial epithelial cell line CFBE41o","volume":"323","author":"Ehrhardt","year":"2006","journal-title":"Cell Tissue Res"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B36","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1091\/mbc.E12-06-0424","article-title":"Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia","volume":"23","author":"Veit","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0896-6273(00)80708-4","article-title":"A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels","volume":"22","author":"Zerangue","year":"1999","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2017.02.024","article-title":"Molecular Structure of the Human CFTR Ion Channel","volume":"169","author":"Liu","year":"2017","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-1-61779-120-8_20","article-title":"CFTR Folding Consortium: Methods available for studies of CFTR folding and correction","volume":"742","author":"Peters","year":"2011","journal-title":"Methods Mol. Biol"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B40","doi-asserted-by":"crossref","first-page":"C866","DOI":"10.1152\/ajpcell.00404.2009","article-title":"Influence of cell background on pharmacological rescue of mutant CFTR","volume":"298","author":"Pedemonte","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B41","doi-asserted-by":"crossref","first-page":"C988","DOI":"10.1152\/ajpcell.1997.273.3.C988","article-title":"Genistein potentiates wild-type and delta F508-CFTR channel activity","volume":"273","author":"Hwang","year":"1997","journal-title":"Am. J. Physiol"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B42","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/mol.115.099689","article-title":"Potentiators of defective DeltaF508-CFTR gating that do not interfere with corrector action","volume":"88","author":"Phuan","year":"2015","journal-title":"Mol. Pharmacol"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B43","author":"Vertex Receives U.S.","year":"2015"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B44"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B45","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jcf.2014.10.001","article-title":"Chronic ivacaftor treatment: getting F508del-CFTR into more trouble?","volume":"13","author":"Mall","year":"2014","journal-title":"J. Cyst. Fibros"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B47","year":"2014"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B48","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S2213-2600(14)70132-8","article-title":"A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial","volume":"2","author":"Boyle","year":"2014","journal-title":"Lancet Respir. Med"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-Ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N. Engl J. Med"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-61779-117-8_4","article-title":"Use of primary cultures of human bronchial epithelial cells isolated from cystic fibrosis patients for the pre-clinical testing of CFTR modulators","volume":"741","author":"Neuberger","year":"2011","journal-title":"Methods Mol. Biol"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B51","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1091\/mbc.E09-12-1004","article-title":"CFTR-adenylyl cyclase I association responsible for UTP activation of CFTR in well-differentiated primary human bronchial cell cultures","volume":"21","author":"Namkung","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"key\n\t\t\t\t20180314012236_ddx367-B52","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1083\/jcb.200808124","article-title":"N-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic","volume":"184","author":"Glozman","year":"2009","journal-title":"J. Cell Biol"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/26\/24\/4873\/24339277\/ddx367.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T01:22:57Z","timestamp":1520990577000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/26\/24\/4873\/4344807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,4]]},"references-count":52,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2017,10,4]]},"published-print":{"date-parts":[[2017,12,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddx367","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12,15]]},"published":{"date-parts":[[2017,10,4]]}}}